tiprankstipranks
SCOR SE (SCRYY)
OTHER OTC:SCRYY
Want to see SCRYY full AI Analyst Report?

SCOR SE (SCRYY) AI Stock Analysis

15 Followers

Top Page

SCRYY

SCOR SE

(OTC:SCRYY)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
$4.50
▲(16.88% Upside)
Action:Reiterated
Date:08/01/26
The score is driven primarily by solid financial performance (strong cash conversion and improved profitability, though with weak revenue growth and historical volatility). Valuation is a meaningful positive (low P/E and high dividend yield). The earnings call was also supportive with reiterated targets and strong ROE/solvency metrics, while technicals are constructive but lack momentum-indicator confirmation.
Positive Factors
Strong cash generation and conversion
Consistently strong cash conversion (FCF ~97% of net income) provides durable internal funding for claim payments, retrocession, dividends and buybacks. Reliable cash flow reduces reliance on external financing and supports capital targets across underwriting cycles.
Negative Factors
Persistently weak revenue growth
Declining top-line trends limit the firm’s ability to scale fixed-cost leverage and restrict premium base expansion. Over time weak revenue growth constrains margin expansion, reduces diversification benefits and makes earnings more dependent on investment and one-off items.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation and conversion
Consistently strong cash conversion (FCF ~97% of net income) provides durable internal funding for claim payments, retrocession, dividends and buybacks. Reliable cash flow reduces reliance on external financing and supports capital targets across underwriting cycles.
Read all positive factors

SCOR SE (SCRYY) vs. SPDR S&P 500 ETF (SPY)

SCOR SE Business Overview & Revenue Model

Company Description
SCOR SE functions as a prominent global reinsurance provider, offering a comprehensive suite of life and non-life protection solutions. The company boasts a broad international footprint, serving clients across Europe, the Middle East, Africa, the...
How the Company Makes Money
SCOR makes money mainly through (1) underwriting reinsurance contracts and (2) investment income on the assets backing its reinsurance liabilities. 1) Reinsurance underwriting (core revenue): - Premiums from cedants: SCOR receives reinsurance pre...

SCOR SE Earnings Call Summary

Earnings Call Date:Jul 30, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Oct 30, 2026
Earnings Call Sentiment Positive
The call conveyed a clearly positive operational and financial tone: strong profitability (ROE well above targets), robust solvency and economic value growth, good P&C underwriting performance, sizable alternative solutions expansion and improving investment/ALM metrics. Headwinds include an arbitration one-off charge, ongoing catastrophe events with uncertain final impact, competitive pressure and price decreases in U.S. property cat renewals, modest net underwriting deterioration and reliance on retrocession. On balance the positive operational results and strengthened capital position materially outweigh the localized challenges and one-off items.
Positive Updates
Strong Profitability and ROE
Group net income of EUR 409 million for H1 2026; adjusted quarterly net income EUR 188 million. Annualized return on equity of 19% for H1 (18% in the quarter), well above the Forward 2026 target of 12%.
Negative Updates
One-off Arbitration Impact in Life & Health
Negative one-off arbitration impact of EUR 64 million included in H1 Life & Health results; Q2 insurance service result was EUR 49 million and would have been EUR 113 million excluding the arbitration charge.
Read all updates
Q2-2026 Updates
Negative
Strong Profitability and ROE
Group net income of EUR 409 million for H1 2026; adjusted quarterly net income EUR 188 million. Annualized return on equity of 19% for H1 (18% in the quarter), well above the Forward 2026 target of 12%.
Read all positive updates
Company Guidance
The group reiterated its Forward 2026 targets and kept its capital-generation guidance at 3–5% net of the dividend accrual while saying it is well positioned to deliver the plan, highlighting a strong set of metrics: adjusted group net income of EUR 188m in Q2 and EUR 409m in H1 (annualized ROE 19% H1; ROE 18% Q2 vs 12% Forward 2026 target), an estimated solvency ratio of 220% (up 5 pts vs YE‑2025 and stable vs Q1 despite deleveraging), economic value of EUR 9bn (+10.5% H1), P&C combined ratio ~79.5% in Q2 (below 80% H1) with a limited 2‑pp underwriting ratio increase at midyear renewals and P&C treaty growth +3.2% YTD, P&C new-business CSM EUR 255m in Q2 / EUR 978m H1, alternative solutions EGPI +133% YTD (premiums >70% growth), Life & Health insurance‑service result EUR 157m H1 (including a –EUR 64m one‑off arbitration; Q2 ISR EUR 49m or EUR 113m ex‑arbitration) with new‑business CSM EUR 216m, investment metrics regular income yield 3.6%, return on invested assets 3.7%, reinvestment rate 4.3%, and an increased asset duration of 4.4 years (from 4.1).

SCOR SE Financial Statement Overview

Summary
Overall financial quality is good, led by strong cash generation (TTM free cash flow ~$0.87B; ~97% of net income) and improved profitability versus the 2022 loss year (TTM net margin ~5.2%, EBIT margin ~24.6%). Offsets include persistently soft revenue (TTM ~-4.4%), multi-year earnings volatility (large loss in 2022; near-breakeven in 2024), and moderately higher leverage versus 2021 (debt ~0.8x equity).
Income Statement
71
Positive
Balance Sheet
63
Positive
Cash Flow
75
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.49B14.80B15.65B15.84B16.44B15.99B
Gross Profit12.88B13.96B14.83B15.16B12.61B12.11B
EBITDA4.51B1.56B520.00M1.58B-1.32B1.23B
Net Income819.55M851.00M4.00M812.00M-1.38B456.00M
Balance Sheet
Total Assets36.55B36.08B37.35B35.61B34.70B47.52B
Cash, Cash Equivalents and Short-Term Investments2.10B2.08B2.39B1.86B1.81B2.09B
Total Debt3.36B3.43B3.45B3.23B3.24B3.17B
Total Liabilities30.14B31.66B32.82B30.87B30.38B41.10B
Stockholders Equity4.41B4.43B4.52B4.71B4.28B6.40B
Cash Flow
Free Cash Flow873.77M973.02M875.00M1.45B430.00M2.32B
Operating Cash Flow907.10M1.01B903.00M1.48B500.00M2.41B
Investing Cash Flow-289.38M-848.15M-181.00M-954.00M-269.00M-1.54B
Financing Cash Flow-606.47M-347.71M-213.00M-428.00M-567.00M-674.00M

SCOR SE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.85
Price Trends
50DMA
3.74
Positive
100DMA
3.67
Positive
200DMA
3.42
Positive
Market Momentum
MACD
0.07
Positive
RSI
56.77
Neutral
STOCH
69.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCRYY, the sentiment is Positive. The current price of 3.85 is below the 20-day moving average (MA) of 3.92, above the 50-day MA of 3.74, and above the 200-day MA of 3.42, indicating a bullish trend. The MACD of 0.07 indicates Positive momentum. The RSI at 56.77 is Neutral, neither overbought nor oversold. The STOCH value of 69.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCRYY.

SCOR SE Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$3.48B6.0221.19%17.41%57.09%
79
Outperform
$13.23B5.4322.68%0.49%-14.15%48.57%
78
Outperform
$14.00B7.8812.43%2.08%-5.12%146.14%
78
Outperform
$16.13B10.7311.29%1.56%19.54%97.85%
75
Outperform
$7.19B7.5418.58%5.81%1.24%64.13%
74
Outperform
$2.72B5.6521.84%22.55%371.77%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCRYY
SCOR SE
3.94
0.74
23.04%
EG
Everest Group
367.38
37.73
11.44%
RGA
Reinsurance Group
244.42
58.57
31.52%
RNR
Renaissancere Holdings
320.72
78.50
32.41%
SPNT
SiriusPoint
23.55
5.31
29.11%
HG
Hamilton Insurance Group, Ltd. Class B
35.26
13.58
62.64%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2026